Navigation Links
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.
Date:8/26/2009

CHADDS FORD, Pa., Aug. 26 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.

FORTESTA, a patented 2 percent testosterone transdermal gel for testosterone replacement therapy in male hypogonadism, utilizes a metered dose delivery system designed to permit accurate dose adjustment to individual patient requirements. This product is in registration in the U.S., where the Food and Drug Administration (FDA) is currently reviewing ProStrakan's New Drug Application submission.

Under the terms of the agreement, Endo Pharmaceuticals has agreed to make an upfront payment to ProStrakan of $10 million, with the potential for up to $40 million more in milestone payments by the end of 2010 for regulatory approval and the achievement of certain commercial milestones. Endo Pharmaceuticals has also agreed to pay ProStrakan an additional $160 million upon the achievement of certain sales targets. ProStrakan will exclusively supply FORTESTA to Endo Pharmaceuticals in the U.S. for an undisclosed supply price.

"We are committed to advancing men's health with effective new medicines. Being in a position to potentially offer this treatment, alongside our new long-acting injectable testosterone product, will help fill an important gap in testosterone replacement," said David Holveck, president and chief executive officer of Endo Pharmaceuticals. "This treatment option is synergistic with our recent therapeutic expansion and strengthens our portfolio in urology and endocrinology."

About FORTESTA

FORTESTA (branded variously as Tostran, Tostrex
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
2. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
3. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
4. Raptor Pharmaceuticals Raises $5 Million
5. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
6. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
7. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
8. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
9. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
10. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
11. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 More than 200 ... to a federal litigation that continues to progress in ... Liebhard LLP reports. , A federal Case List ... over the widely-used cholesterol medication by plaintiffs who developed ... to claims, Pfizer Inc. failed to adequately warn patients ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Bioinformatics ... organize and analyze biological and genetic data. A ... activity of developing software tools to generate and ... be confused with biological computation. While bioinformatics simply ... of biology can its related concepts, biological computation ...
(Date:9/1/2014)... NJ (PRWEB) September 01, 2014 Registration is ... The Warriors® 5K and 1-Mile Race to be held on ... The Plaza Court Yard at Harmon Meadow in Secaucus, New ... The Warriors®, a national nonprofit dedicated to restoring a sense ... our service members and our military families. , General registration ...
Breaking Medicine News(10 mins):Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2
... PHOENIX, July 1 The boards of ... Long Term Care announced today the appointment ... operations, effective,immediately. In Arizona, SCAN offers a ... also provides long-term care services to,individuals enrolled ...
... & Ellis Healthcare,REIT, Inc. today announced the acquisition ... properties comprising 20 buildings,located throughout Indianapolis., Medical ... of,gross leaseable area. The portfolio is 91 percent ... which has occupancy in nine of the 13,properties ...
... processing in brain, affect development, researcher says , , TUESDAY, ... intensive care must undergo numerous painful interventions, not enough ... suggests. , Of the 42,413 painful procedures included in ... medications, and just 18.2 percent received non-pharmacological pain therapy. ...
... by University of Michigan scientists suggest that people who experience ... different forms of the disease that require different kinds of ... point to a time when doctors will be able to ... help MS patients, using available drugs and new ones in ...
... for better treatments of certain malignancies , , TUESDAY, July 1 ... a kind of dimmer switch to stop a "cancer signal" ... don,t represent a cure, and no one knows if they ... research does clear a pathway for scientists to follow as ...
... Insurance Services,Inc., has been sold to Assurance Investment Partners ... Shield in Kentucky, Arison has six,offices across Kentucky and ... individuals., The company will continue to operate under ... employees will be employed by AIP. Paul,Anderson, who served ...
Cached Medicine News:Health News:SCAN Health Plan Arizona and SCAN Long Term Care Appoints Thomas Lescault President of Arizona Operations 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 3Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:Best treatment for MS may depend on disease subtype 2Health News:Best treatment for MS may depend on disease subtype 3Health News:Scientists Find Way to Dim Cancer Switch 2Health News:Assurance Investment Partners Purchases Arison Insurance Services from Anthem Blue Cross and Blue Shield 2
(Date:8/29/2014)... 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the ... turnkey support services for the lawfully organized cannabis ... and approved the Company,s name and symbol change ... will be known as Chuma Holdings, Inc. ... a merger with the Company,s wholly-owned subsidiary, Chuma ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... 2011 Boston Scientific Corporation (NYSE: BSX ... the First Circuit has affirmed the dismissal of a ... Company,s TAXUS® Express2 Paclitaxel-Eluting Coronary Stent System in 2004. ... Public Employees, Retirement System, had previously been dismissed by ...
... 2011 CareFusion Corp. (NYSE: CFN ), a ... quarter and fiscal year ended June 30, 2011. ... margin expansion and the benefit of strong spending controls drove ... quarter and for the year," said Kieran Gallahue, chairman and ...
Cached Medicine Technology:Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 2Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 2CareFusion Reports Fourth Quarter and Fiscal 2011 Results 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 4CareFusion Reports Fourth Quarter and Fiscal 2011 Results 5CareFusion Reports Fourth Quarter and Fiscal 2011 Results 6CareFusion Reports Fourth Quarter and Fiscal 2011 Results 7CareFusion Reports Fourth Quarter and Fiscal 2011 Results 8CareFusion Reports Fourth Quarter and Fiscal 2011 Results 9CareFusion Reports Fourth Quarter and Fiscal 2011 Results 10CareFusion Reports Fourth Quarter and Fiscal 2011 Results 11CareFusion Reports Fourth Quarter and Fiscal 2011 Results 12CareFusion Reports Fourth Quarter and Fiscal 2011 Results 13CareFusion Reports Fourth Quarter and Fiscal 2011 Results 14CareFusion Reports Fourth Quarter and Fiscal 2011 Results 15
... are built to deliver maximum ... The systems have the capacity ... in todays environment. Plus, ... and maximize user-friendliness, the UniCel ...
... is a unique double loaded anchor perfect for ... Poly-L Lactic Acid (PLLA) and comes in two ... the suture ends for open repairs, and can ... tip inserter allows insertion with minimal procedural steps ...
... The E-Z Tac™ implantThe USS Sports Medicine™ E-Z ... to attach soft tissue to bone. The resorbable ... in the bone and is used to reattach ... made of a resorbable copolymer, a polyester derivative ...
Umbrella Cancellous Harpoon...
Medicine Products: